Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Durant

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|May 1, 1970
Prolonged immunological disorder terminating in hematological malignancy: A human analogue of animal disease?R R Joseph, C D Tourtellotte, W E Barry, et al.
Cancer Research|March 1, 1977
cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104EV K Ghanta, M T Jones, D A Woodard, et al.
Cancer|November 1, 1978
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's diseaseJ R Durant, R A Gams, E Velez-Garcia, et al.
Journal of the Medical Association of the State of Alabama|June 1, 1970
A proposal for the management of Hodgkin's disease at The University of Alabama Medical Center Birmingham, AlabamaD J Brascho, J R Durant, F G Moody, et al.
Biochemical and Biophysical Research Communications|December 31, 1982
Human tumors as examined by in vivo 31P NMR in athymic miceW T Evanochko, T C Ng, J D Glickson, et al.
Annals of Internal Medicine|February 1, 1979
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU)J R Durant, M J Norgard, T M Murad, et al.
Methods of Information in Medicine|July 1, 1976
Clinical algorithms for cancer chemotherapy--systems for community-based consultant-extenders and oncology centersE Mesel, D D Wirtschafter, J T Carpenter, et al.
Cancer|October 11, 1975
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's diseaseC M Huguley, J R Durant, R R Moores, et al.
Blood|October 1, 1979
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myelomaH J Cohen, H R Silberman, W E Larsen, et al.
Cancer|March 15, 1982
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapyC M Balch, R V Smalley, A A Bartolucci, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|May 1, 1970
Prolonged immunological disorder terminating in hematological malignancy: A human analogue of animal disease?R R Joseph, C D Tourtellotte, W E Barry, et al.
Cancer Research|March 1, 1977
cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104EV K Ghanta, M T Jones, D A Woodard, et al.
Cancer|November 1, 1978
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's diseaseJ R Durant, R A Gams, E Velez-Garcia, et al.
Journal of the Medical Association of the State of Alabama|June 1, 1970
A proposal for the management of Hodgkin's disease at The University of Alabama Medical Center Birmingham, AlabamaD J Brascho, J R Durant, F G Moody, et al.
Biochemical and Biophysical Research Communications|December 31, 1982
Human tumors as examined by in vivo 31P NMR in athymic miceW T Evanochko, T C Ng, J D Glickson, et al.
Annals of Internal Medicine|February 1, 1979
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU)J R Durant, M J Norgard, T M Murad, et al.
Methods of Information in Medicine|July 1, 1976
Clinical algorithms for cancer chemotherapy--systems for community-based consultant-extenders and oncology centersE Mesel, D D Wirtschafter, J T Carpenter, et al.
Cancer|October 11, 1975
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's diseaseC M Huguley, J R Durant, R R Moores, et al.
Blood|October 1, 1979
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myelomaH J Cohen, H R Silberman, W E Larsen, et al.
Cancer|March 15, 1982
A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): prognostic factors analysis and preliminary results of immunotherapyC M Balch, R V Smalley, A A Bartolucci, et al.
Pageof 8